Formycon Overview

  • Founded
  • 1999
  • Status
  • Public
  • Employees
  • 131
  • Stock Symbol
  • FYB
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $72.67
  • (As of Friday Closing)

Formycon General Information


Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Primary Office
  • Fraunhoferstraße 15
  • Planegg
  • 82152 Martinsried
  • Germany
+49 089 000000000

Formycon Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Formycon Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$72.67 $72.45 $24.41 - $96.81 $799M 11M 8.09K -$0.68

Formycon Financials Summary

In Thousands,
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 694,314 694,314 348,281 264,239
Revenue 39,016 39,016 37,118 50,735
EBITDA (5,488) (5,488) (1,524) 9,476
Net Income (6,755) (6,755) (2,567) 8,377
Total Assets 92,984 92,984 59,991 45,326
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Formycon Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Formycon‘s full profile, request access.

Request a free trial

Formycon Executive Team (3)

Name Title Board Seat Contact Info
Carsten Brockmeyer Ph.D Chief Executive Officer
Nicolas Combé Ph.D Chief Financial Officer
Stefan Glombitza Ph.D Chief Operating Officer
To view Formycon’s complete executive team members history, request access »

Formycon Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Formycon Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Formycon‘s full profile, request access.

Request a free trial

Formycon Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 22-Dec-2017 00000 0000000 Biotechnology
Scil Technology (R&D & Service Units) 31-Dec-2011 Merger/Acquisition Discovery Tools (Healthcare)
To view Formycon’s complete investments and acquisitions history, request access »